The Future of Life Sciences Manufacturing through a Client’s Eyes
2019 was a watershed year for life sciences manufacturing. It was a year when terms such as Industry 4.0, digitization, Internet of Things (IoT), advanced analytics and cybersecurity were at the forefront of all business discussions. As we moved into 2020, no one could have predicted the COVID-19 outbreak and lasting repercussions that have sent […]
Read MoreIt’ll Take New Tools and Partnerships to Fast-Track Clinical Trials for a COVID-19 RX
As we adjust to life under COVID-19, I wonder if things will ever be the same again. From my new home office in the dining room, a world that once seemed so small – just a day’s flight from one end of the globe to another – now seems out of reach. The impact of […]
Read MoreDisaggregation of Healthcare: The Great Unbundling Proceeds
In discussions with our clients, it’s become apparent that one of the greatest changes we’re witnessing in healthcare is the disaggregation (or unbundling) of care. Historically, access to and delivery of healthcare took place primarily in doctors’ offices, hospitals and clinics. However, changes in consumer sentiment and advances in technology are creating a far more […]
Read MoreFrom ‘-Omics’ to Digital Twins, Life Sciences Is In for Vast Changes Ahead
Digital tools and platforms are remaking every aspect of the life sciences (LS) value chain, from co-prescribed apps to implanted sensors to data queries for drug discovery, and digital is overturning how companies conduct clinical trials and manage production/distribution. The changes extend to how individual patients assimilate and internalize health and healthcare technology directly, through […]
Read More